PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
23371447-6	2013	A new CYP17 inhibitor, with more selective inhibition of 17,20-lyase over 17alpha-hydroxylase, orteronel (TAK-700), is currently undergoing phase III clinical trials in pre- and postchemotherapy CRPC.	orteronel	95-104	cytochrome P450 family 17 subfamily A member 1	Homo sapiens	6-11	
23371447-6	2013	A new CYP17 inhibitor, with more selective inhibition of 17,20-lyase over 17alpha-hydroxylase, orteronel (TAK-700), is currently undergoing phase III clinical trials in pre- and postchemotherapy CRPC.	orteronel	106-113	cytochrome P450 family 17 subfamily A member 1	Homo sapiens	6-11